The development is set to make India less reliant on China for imports of raw material used by the pharmaceutical industry.

The other important drugs like Prednisolone, Betamethasone and Dexamethasone are also expected to be commissioned this year.

The Department of Pharmaceuticals has sought expressions of interest from interested entities for project funding under the ...

The scheme for Promotion of Research and Innovation in Pharma MedTech sector (PRIP) will boost cost-effective and affordable ...

Shri Amit Agrawal highlighted the rapid expansion of the sector, emphasizing India’s growing role in research and innovation.

The Department of Pharmaceuticals, Government of India, organised an Industry dialogue on the Promotion of Research and ...

Bigger companies can seek funding of up to ₹125 crore while startups can secure funding of ₹1 crore, over a period of five ...

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

PRIP Scheme to Foster Affordable Healthcare Innovation in India - The Government of Indias Department of Pharmaceuticals organized an industry forum in Mumbai ...

Valued at $50 billion, the Indian pharmaceutical sector continues to grow, fueled by cost efficiency, cutting-edge ...

Scheme not only benefits the domestic economy but also has positive ripple effects on the global stage, enhancing ...